LOX and Hepatic fibrosis: It is therefore likely that TG2 does not have a major contribution to hepatic fibrogenesis or stabilization of the collagen matrix and that TG2-independent collagen cross-linking (e.g., LOX family) could be represented as an important therapeutic target for liver fibrosis [36].